Login / Signup
Reduced moxifloxacin exposure in patients with tuberculosis and diabetes.
Bart G J Dekkers
Mathieu S Bolhuis
Lies Ter Beek
Wiel C M de Lange
Tjip S van der Werf
Jan-Willem C Alffenaar
Onno W Akkerman
Published in:
The European respiratory journal (2019)
Keyphrases
</>
type diabetes
mycobacterium tuberculosis
cardiovascular disease
glycemic control
pulmonary tuberculosis
hiv aids
metabolic syndrome
antiretroviral therapy